IngentaConnect Gastric damage in the rat with nitrogen-containing bisphosphonate...

Authors: Blank¹; Gibson¹; Myers¹; Dierckman¹; Phipps¹; Smith¹

Source: Alimentary Pharmacology & Therapeutics, Volume 14, Number 9, September 2000 , pp. 1215-1223(9)

Abstract:

Background:

The use of nitrogen-containing bisphosphonates (N-BPs) has been reported to be associated with gastrointestinal intolerance. The fasted, indomethacin-treated rat provides a model for assessing the gastrointestinal effects of these compounds. Aims:

The aims of this study were to elucidate the effect of pH on N-BP-induced gastric damage, and to evaluate the structure-activity relationship between N-BP anti-resorptive and gastric effects. Methods:

Fasted rats were dosed concomitantly with indomethacin (40 mg/kg, subcutaneously) and an N-BP (pamidronate, alendronate, or risedronate at 150 or 300 mg/kg, orally), with the N-BP dosing solutions adjusted to pH 2, 4 or 7. The aminopentane and aminohexane N-BPs (150, 225 or 300 mg/kg, orally) were only tested at pH 4 only. Results:

Nitrogen-containing bisphosphonate-induced gastric damage was pH-dependent, with increased damage at increasing pH. Conclusions:

Gastric damage potential did not correlate with bone anti-resorptive effects, and the more potent anti-resorptive N-BPs were not necessarily more damaging to the stomach.

Document Type: Research article

DOI: 10.1046/j.1365-2036.2000.00816.x

Affiliations: 1: Department of Drug Safety Assessment, Procter & Gamble Pharmaceuticals, Health Care Research Center, 8700 Mason-Montgomery Road, Cincinnati, Ohio, USA

You have access to the full text article on a website external to Ingentaconnect.

Please click here to view this article on InterScience.

You may be required to register and activate access on InterScience before you can obtain the full text. If you have any queries please contact onlinehelp@oxon.blackwellpublishing.com

Gastric damage in the rat with nitrogen-containing bisphosphonates depends on pH